Gilead Sciences nelle notizie
Sviluppo di soluzioni sanitarie innovative
Tamtam ha trovato 20 articoli recenti su Gilead Sciences.
- Gilead Accelerates Global Access Planning for Investigational Once-Yearly Lenacapavir for HIV Prevention
- Gilead, PAHO agree on HIV prevention drug access in Latin America, Caribbean
- Gilead Partners With Pan American Health Organization on Lenacapavir Access for Latin America, Caribbean
- PAHO opens a new pathway to access lenacapavir for HIV prevention in Latin America and the Caribbean
- Should Gilead Sciences (GILD) Reconsider Its Global HIV Case After This PAHO Deal?
- Atlanta Black Pride Weekend celebrates 20 years, powered by Gilead Sciences
- Andrew Dickinson Sells 3,000 Shares of Gilead Sciences (NASDAQ:GILD) Stock
- CEO O’Day tells Fierce how Gilead’s cancer, inflammation expansion has reached ‘critical mass’
- Gilead Sciences Inc's Dividend Analysis
- Gilead Sciences Eyes HIV, Oncology Catalysts as Pipeline Enters Execution Mode
- Gilead Sciences Sees Sunlenca Launch Fueling Long-Term HIV Growth
- 'I've Said A Lot Of Thirsty Things At 2 A.M.' — Nicole Byer Says This One Question Belongs In Every Booty Call Conversation [Exclusive]
- Gilead Sciences at 12th Annual Cantor Fitzgerald Global Healthcare Conference: broader growth
- Gilead Opens State of the Art Research Center to Advance the Next Generation of Medicines
- Gilead opens new building on existing Foster City campus
- Gilead opens new research center at Foster City headquarters
- Gilead opens new research centre bringing together oncology, inflammation and research data science teams
- Gilead launches research facility in US for new medicine development
- How Bixlenvo Approval At Gilead Sciences (GILD) Has Changed Its Investment Story
- Assembly Bio converts HSV program from royalty deal to 40% US profit-share with Gilead
Articoli raccolti da Tamtam e conservati quando riguardano l'azienda, dal più recente. Ognuno rimanda alla sua fonte.
Vendi ad aziende come Gilead Sciences?
Tamtam trova le aziende in linea con il tuo cliente ideale, analizza ogni account e ti dice chi contattare e quando.
Trova aziende simili